MD1561Z - Method for complex treatment of SARS-CoV-2 virus infection - Google Patents

Abstract

The invention relates to medicine, in particular to infectious diseases and pneumology, and can be used for complex treatment of SARS-CoV-2 virus infection.Summary of the invention consists in that it is administered azithromycin 500 mg once a day for 9 days, cefuroxime 500 mg 1 tablet 2 times a day, for 14 days, enoxaparin sodium solution 0.4 ml 2 times a day, subcutaneously, for 5 days, deflazacort 45 mg, for 3 days, then 37.5 mg, for 3 days, then 30 mg, for 5 days, then 22.5 mg, for 5 days, then 15 mg, for 6 days, acetylcysteine 600 mg once a day, for 10 days; adjuvant therapy with the use of gastroprotective drugs, drugs that affect the energy metabolism of the body, amino acids, drugs to improve the intestinal biocenosis and sedatives; simultaneously is intravenously administered 500 ml of 0.9% NaCl ozonated solution with an oxygen-ozone mixture, with an ozone concentration of 5 µg/mL once a day, for 7 days, then prolonged with the specified solution with the ozone concentration of 3 µg/mL once a day, for 5 days, nasal and rectal insufflations are also performed with an oxygen-ozone mixture, at the same time the nasal insufflations are performed with a mixture with ozone concentration of 10 µg/mL, which are performed for 5…7 min, daily, for 12 days, and rectal insufflations are performed by administering 150…300 mL of a mixture with ozone concentration of 10…25 µg/mL, daily, for 7 days.